Michael Varney

Michael D.
Varney currently serves as Director, Chairman-Research & Development at Erasca, Inc. since 2020.
He is Lead Independent Director at Numerion Labs, Inc. starting in 2025.
He holds the position of Director at Affini-T Therapeutics, Inc. since 2022.
He is a Senior Advisor at Frazier Management LLC since 2020.
He is also a Trustee at The California Academy of Sciences.
Formerly, Dr. Varney was Director at Foundation Medicine, Inc. from 2015 to 2018.
He was Independent Director at Pardes Biosciences, Inc. from 2021 to 2023.
He served as Head-Research at Agouron Pharmaceuticals LLC from 1987 to 2005.
He was Executive VP, Head-Research & Early Development at Genentech, Inc. from 2015 to 2020.
He held the role of Head-Genentech Research & Early Development at Roche Holding AG.
He was Vice President-Drug Discovery at Pfizer (St. Louis) from 2000 to 2005.
Dr. Varney completed undergraduate studies at the University of California, Los Angeles in 1980 and earned a doctorate from the California Institute of Technology in 1985.